Last checked at 10 Oct 2017 09:50
10 October 2017
Kromek Group plc
("Kromek" or the "Company" or the "Group")
Director/PDMR Shareholdings
Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security and nuclear markets, announces that it has received notification of the following purchases by Directors of Ordinary Shares of 1 pence each ("Ordinary Shares") in the Company:
Director | Position | Date of transaction | Number of Ordinary Shares purchased in the transaction | Price at which Ordinary Shares were purchased | Number of Ordinary Shares held post transaction | Percentage of share capital held post transaction |
Derek Bulmer | Chief Financial Officer | 9 October 2017 | 36,066 | 24.4p | 100,000 | 0.04% |
Lawrence Kinet | Non-executive Director | 4 October 2017 | 50,000 | 23.5p | 250,000 | 0.10% |
Enquiries:
Kromek Group plc | +44 (0)1740 626 060 |
Arnab Basu, CEO Derek Bulmer, CFO |
|
|
|
Cenkos Securities plc | +44 (0)20 7397 8900 |
Bobbie Hilliam (NOMAD) Julian Morse (Sales) |
|
|
|
Luther Pendragon Ltd | +44 (0)20 7618 9100 |
Harry Chathli, Claire Norbury, Alexis Gore |
|
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Derek Bulmer | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Chief Financial Officer | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Kromek Group plc | ||||
b)
| LEI
| N/a | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of 1p each
GB00BD7V5D43
| ||||
b)
| Nature of the transaction
| Purchase of Ordinary Shares | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
36,066 Ordinary Shares
24.4p per Ordinary Share
| ||||
e)
| Date of the transaction
| 9 October 2017
| ||||
f)
| Place of the transaction
| London Stock Exchange | ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Lawrence Kinet | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Non-Executive Director | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Kromek Group plc | ||||
b)
| LEI
| N/a | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of 1p each
GB00BD7V5D43
| ||||
b)
| Nature of the transaction
| Purchase of Ordinary Shares | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
50,000 Ordinary Shares
23.5p per Ordinary Share
| ||||
e)
| Date of the transaction
| 4 October 2017
| ||||
f)
| Place of the transaction
| London Stock Exchange | ||||
About Kromek Group plc
Kromek Group plc is a UK technology Group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.
The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.
The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").
The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.
Currently, the Group has over one hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.